MedTrace Logo

SMART Trial: Community Stigma Reduction

NCT05075330 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 199

Last updated 2022-03-18

No results posted yet for this study

Summary

The goal of this project is to engage community members from two low-income African American communities (N=200) in a survey study that assesses stigma toward those with Opioid Use Disorder (OUD). Those from the intervention community will be subject to a stigma reduction campaign via billboards. Those from the control community will not. Stigma will be re-assessed following the period of the campaign.

Conditions

  • Opioid-use Disorder
  • Stigma, Social

Interventions

BEHAVIORAL

Opioid Use Disorder Stigma Reduction

Billboards with destigmatizing language regarding opioid use disorder placed in the community.

Sponsors & Collaborators

  • National Center for Complementary and Integrative Health (NCCIH)

    collaborator NIH

  • Karen Derefinko, PhD

    lead OTHER

Principal Investigators

  • Karen Derefinko, PhD · University of Tennessee

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-16
Primary Completion
2021-08-19
Completion
2021-08-19

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05075330 on ClinicalTrials.gov